RadioimmunotherapyYttrium RadioisotopesColonic NeoplasmsRadioisotopesRheniumLutetiumIodine RadioisotopesAntibodies, MonoclonalHeterocyclic Compounds, 1-RingRadiometryAlpha ParticlesMice, NudeIndium RadioisotopesBismuthTissue DistributionRadiotherapy DosageCarcinoembryonic AntigenAntigens, CD20Lead RadioisotopesNeoplasm TransplantationAstatinePentetic AcidRadioimmunodetectionCell Line, TumorTransplantation, HeterologousHT29 CellsLymphoma, Non-HodgkinActiniumRadiopharmaceuticalsColorectal NeoplasmsAntibodies, BispecificStreptavidinImmunoconjugatesImmunotoxinsXenograft Model Antitumor AssaysYtterbiumDose-Response Relationship, RadiationCombined Modality TherapyAntineoplastic AgentsAdenocarcinomaAntibodies, NeoplasmCopper RadioisotopesNeoplasmsColon, DescendingLymphoma, B-CellRadiation DosageEarly Detection of CancerTumor Cells, CulturedGene Expression Regulation, NeoplasticNeoplasm MetastasisHCT116 CellsHematologyNeptuniumSialic Acid Binding Ig-like Lectin 2Isotope LabelingOvarian NeoplasmsProstatic NeoplasmsBiotinHeterocyclic CompoundsMice, Inbred BALB CBreast NeoplasmsOrganometallic CompoundsLung NeoplasmsBeta ParticlesTreatment OutcomeAvidinNeoplasm InvasivenessApoptosisAntigens, NeoplasmNeoplasms, ExperimentalSurvival AnalysisAntibodies, Monoclonal, Murine-DerivedAzoxymethaneAntibodies, Monoclonal, HumanizedCell ProliferationPeritoneal NeoplasmsBone MarrowColon, SigmoidSurvival RateNeoplasm ProteinsImmunoglobulin FragmentsLymphoma, FollicularAntineoplastic Combined Chemotherapy ProtocolsWhole-Body CountingPancreatic NeoplasmsRectal NeoplasmsAntineoplastic Agents, PhytogenicRNA, MessengerDrug Delivery SystemsStomach NeoplasmsReverse Transcriptase Polymerase Chain ReactionFluorouracilNeoplasm StagingTime FactorsRadiation-Sensitizing AgentsCell DivisionImmunoglobulin Fab FragmentsNuclear MedicineDisease ProgressionDisease-Free Survival